DEPARTMENT OF REGENERATIVE MEDICINE
Stem cells are available in Embryo, Umbilical Cord Blood, Wharton's jelly etc.,
we at Deepam with NCRM are using ONLY the autologous (patients own) cells taken from bone marrow.
We Dont Use Embryonic Stem Cells or Umbilical Cord Blood Cells or any other material from either from human beings or animal source.
At the present moment following diseases/conditions are dealt with*:
- Critical limb ischemia / ischemic ulcer of the leg, foot especially in diabetic patients untreatable with conventional treatments such as bypass surgery
- Ischemic heart diseases and cardiomyopathy untreatable with conventional treatments such as angioplasty, stents or bypass surgery
- Spinal cord injury and neurological trauma where the patient has no conventional treatment available and left paraplegic
- Cirrhosis of Liver
ONCOLOGY :
one very useful latest weapon would be AIET (Autologus Immune Enhancement Therapy)
AIET is a treatment method in which some immune cells are taken out of a patient's body which are cultured and processed to be activated or to acquire additional functions until their resistance to cancer is strengthened, then the cells are put back in the body.
The cells, antibodies, and organs of the immune system work to protect and defend the body against not only tumor cells but also foreign invaders, such as bacteria or viruses.
Researchers have found that the thus activated immune system might also be able to determine the difference between healthy cells and cancer cells to eliminate the cancer cells from the body.
- Upon encountering a tumor cell, the activated NK cell attaches to the membrane of the cancer cell and injects toxic granules that quickly dissolve the target cell. In less than five minutes, the cancer cell would be dead and the NK cell moves on to its next target. A single NK cell can destroy up to 27 cancer cells before it dies.
- At present our protocol is based on reported clinical experiences from Japan and other developed nations, well accepted by the scientific community.
- Peripheral blood of the cancer patients (during remission in patients who undergo chemotherapy) is drawn and by proven methods, the peripheral blood mononuclear cells are separated.
- These cells are expanded in vitro during which they expand to 25-30 fold around 2-3 weeks. After expansion, the activated lymphocytes and NK cells are injected into the patient’s body wherein these cells act against the cancer cells effectively and also repopulate the patient’s peripheral blood cells thereby recharging the immune system.
Consultants
Dr. Samuel JK Abraham: A cardiac surgeon working at the II Dept of surgery, Yamanashi university hospital, Japan, originally from India.
Dr. A. Pandian, M.B.,D.A., (Clinical Co-ordinator), Director Deepam Hosptial (P) Ltd
 |
  |
"In this world everything needs improvement in general, but in your hospital I find that continuous improvement round the clock is going on which should be kept up. Its really a world-class experience for me."
- Mr. S.N. Aggarwal - Chennai.
